Sleep Apnea Diagnostic Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033

Sleep Apnea Diagnostic Systems Market Report Overview

The Sleep apnea diagnostic systems market size was $898.8 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. Sleep apnea diagnostic systems include polysomnography systems (PSG systems), which is used for the screening of sleep apnea.

Sleep Apnea Diagnostic Systems Market Outlook, 2023-2033 ($ Million)

Buy Full Report for More Insights into the Sleep Apnea Diagnostic Systems Market Forecast

Download a Free Report Sample

The Sleep Apnea Diagnostic Systems market research report provides insights into the market behavior, which will help identify quantitative market trends within the Digital Health Devices therapeutic area. The model discusses in detail the impact of COVID-19 on the sleep apnea diagnostic systems market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.

Sleep Apnea Diagnostic Systems Market Dynamics

Sleep apnea diagnostic systems, also called computerized polysomnography (PSG) analyzers, or sleep testing systems, monitor and record a variety of physiologic parameters during sleep. These systems are used in the diagnostic evaluation of sleep and sleep-related disorders.

Product innovation is one of the main drivers for the market growth. The new technologies of PSG, including more channels, stronger recording capabilities, data retrieval and storage abilities, and user-friendly interface, continue to improve patient outcomes, ease of use, and efficiency. Furthermore, the software of the diagnostic systems has been improved greatly. A wide variety of software is available, enabling the devices to stage sleep into appropriate phases of REM and non-REM, to score respiratory disorders, and to search through accumulated data of apnea, hypopnea, and other breathing difficulties.

The other key driver for the market growth is the shift care from hospital to home. Conventional lab-based sleep testing can pose challenges for sleep clinicians and patients, including limited availability and cost. Having the test at home allows reliable and accurate diagnosis of Obstructive Sleep Apnea (OSA) that is more accessible, cost-effective, and efficient.

Sleep Apnea Diagnostic Systems Market Segments

The sleep apnea diagnostic systems market can be segmented into Fixed Polysomnography Systems and Portable Polysomnography Systems. Fixed Polysomnography Systems led the sleep apnea diagnostic systems market in 2023. Fixed Polysomnography System monitors many body functions, including brain (EEG), eye movements (EOG), muscle activity or skeletal muscle activation (EMG) (chin/limb), heart rhythm (ECG), and breathing function or respiratory effort during sleep. They are used in hospitals, sleep clinics and Ambulatory Surgery Centers (ASCs).

Sleep Apnea Diagnostic Systems Market Analysis by Segments, 2023 (%)

Buy Full Report for More Insights into the Sleep Apnea Diagnostic Systems Market Segments

Download a Free Report Sample

Sleep Apnea Diagnostic Systems Market Segmentation by Regions

The key regions in the sleep apnea diagnostic systems market are North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. North America accounted for the largest share of the sleep apnea diagnostic systems market revenue in 2023 due to its increasing population and growing awareness of the devices. Furthermore, the use of the devices is increasing rapidly in home care settings due to its effectiveness, portability, and cost-effective nature. The long-term trend of cost-containment, through managed healthcare or other legislative proposals to reform healthcare, could control or influence the purchase of healthcare services and products. This, in turn, can lower prices of the devices.

Sleep Apnea Diagnostic Systems Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Insights into the Sleep Apnea Diagnostic Systems Market Regions

Download a Free Report Sample

Sleep Apnea Diagnostic Systems Market - Competitive Landscape

Some of the leading companies in the sleep apnea diagnostic systems market are:

• Koninklijke Philips NV
• ResMed Inc
• Natus Medical Inc
• Somnomedics GmbH
• Compumedics Ltd
• Nihon Kohden Corp

Natus Medical Inc was the leading revenue contributor in the sleep apnea diagnostic systems market in 2023. It is followed by ResMed Inc.

Sleep Apnea Diagnostic Systems Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Insights into the Sleep Apnea Diagnostic Systems Market Companies

Download a Free Report Sample

Segments Covered in the Report

Sleep Apnea Diagnostic Systems Segments Outlook (Value, $ Million, 2015-2033)

• Fixed Polysomnography Systems
• Portable Polysomnography Systems

Sleep Apnea Diagnostic Systems Regional Outlook (Value, $ Million, 2015-2033)

• North America
• Europe
• Asia Pacific
• South and Central America
• Middle East and Africa

Key Inclusions

Currently marketed sleep apnea diagnostic systems and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total sleep apnea diagnostic systems market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the sleep apnea diagnostic systems market.
• Competitive dynamics insights and trends provided for the sleep apnea diagnostic systems market.

Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Koninklijke Philips NV, ResMed Inc, Natus Medical Inc, Somnomedics GmbH, Compumedics Ltd, Nihon Kohden Corp, Heinen + Lowenstein GmbH & Co. KG, Cadwell Industries Inc, Cleveland Medical Devices Inc, Advanced Brain Monitoring Inc, BMC Medical Co Ltd, Braebon Medical Corp, MEDATEC Sprl, Nox Medical, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:

• CMO executives who must have deep understanding of the sleep apnea diagnostic systems marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

• Understand the impact of COVID-19 on sleep apnea diagnostic systems market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving sleep apnea diagnostic systems market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the sleep apnea diagnostic systems market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
• Track device sales in the global and country-specific sleep apnea diagnostic systems market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.